Nucleotides are indispensable components of all living cells, as they make up DNA and RNA, and serve as important energy sources. Nucleotides also have key roles in signalling in eukaryotic, bacterial and archaeal cells. In bacteria, signalling nucleotides such as cyclic AMP and guanosine tetra-or pentaphosphate ((p)ppGpp) have been classically linked to carbon metabolism and the stringent response, which is caused by nutrient limitation 1, 2 . However, it has become clear that signalling nucleotides contribute to the regulation of multiple different pathways; for example, in addition to its involvement in central carbon metabolism, cAMP is also involved in the regulation of both biofilm formation and virulence gene expression in many pathogenic bacteria 1 . One of the latest signalling nucleotides to be identified is cyclic di-AMP (c-di-AMP), which is the second cyclic dinucleo tide shown to be produced by bacteria, after cyclic di-GMP (c-di-GMP) 3 
. However, as we discuss in this Review, c-di-AMP and c-di-GMP regulate very different processes.
c-di-AMP is produced from two molecules of ATP by diadenylyl cyclase (DAC) enzymes and is degraded to pApA by phosphodiesterase (PDE) enzymes (FIG. 1) . The dinucleotide was initially discovered during a structural study on Thermotoga maritima DNA integrity scanning protein (DisA) 4 , which is a homologue of Bacillus subtilis DisA (formerly known as YacK), a bacterial DNA damage checkpoint protein that can delay sporulation in the event of DNA damage 5 . The first report of c-di-AMP production by bacterial cells came in 2010, when the dinucleotide was identified as a molecule secreted into the cytosol of host cells by the intracellular bacterial pathogen Listeria mono cytogenes 6 . Since then, c-di-AMP has been detected in cellular extracts from Streptococcus pyogenes 7 , B. sub tilis 8 , Chlamydia trachomatis 9 and Staphylococcus aureus 10 , and a DisA-type c-di-AMP-synthesizing enzyme from Mycobacterium tuberculosis has been characterized biochemically 11 . As previously suggested 12 and further analysed here, c-di-AMP is likely to be widely distributed among bacteria and is also found in a subset of archaea. Here, we propose a unifying nomenclature for DAC enzymes on the basis of their domain architecture.
Although most of the mechanistic details still await molecular characterization, the regulation of cellular pathways by c-di-AMP presumably follows the same general principles as for the other signalling nucleotides. Environmental changes are sensed either directly or indirectly by the nucleotide-synthesizing or nucleotidedegrading enzymes, leading to a change in the cellular nucleotide concentration. At high concentrations, c-di-AMP is expected to bind to a specific set of receptor or target proteins and allosterically alter their function or the function of downstream effector proteins, thus controlling specific cellular pathways (FIG. 1) . Although many details of the c-di-AMP signalling network remain to be discovered, this nucleotide has been linked to the regulation of fatty acid synthesis in Mycobacterium smeg matis 13 , to the growth of S. aureus in low-potassium conditions
Nucleotidyl transferase superfamily
A family of enzymes that transfer nucleotides onto phosphosugars.
in its production and degradation, and our current understanding of how this second messenger is involved in the control of diverse cellular pathways.
Synthesis of c-di-AMP c-di-AMP is synthesized from two molecules of ATP by proteins containing a DisA_N domain (Pfam accession PF02457) (FIG. 1) . This domain was first identified as a DAC domain in the T. maritima protein DisA 4 . On the basis of its function as a DAC, DisA_N is referred to hereafter as a DAC domain. In DisA proteins, the amino-terminal DAC domain is connected through a specific linker domain (DisA_N linker; PF10635) to a carboxy-terminal helix-hairpin-helix (HhH; PF12826) DNA-binding domain. Eight DisA monomers form the functional octameric protein complex 4 . During crystallization studies on T. maritima DisA, an extra electron density was noted within the DAC domain and was identified as c-di-AMP 4 . It was further shown that, in the presence of divalent cations, DisA proteins synthesize c-di-AMP through the condensation of two molecules of ATP, each bound to a different subunit of the octamer 4, 11 . The ligand-bound crystal structure of DisA revealed the presence of DGA and RHR amino acid motifs within the DAC domain 4 . These motifs are conserved within all bacterial DAC domain-containing proteins, and a crucial function for these motifs in the cyclase reaction has been confirmed experimentally 4, 11 . The DAC domain bears no amino acid or structural similarity to the GGDEF domain of diguanylyl cyclases (DGCs) (PF00990). The observation that evolutionarily unrelated proteins have evolved for the synthesis of cyclic dinucleotides is further underscored by the recent identification of the dinucleotide cyclase DncV, which produces 3′-5′-linked cyclic GMP-AMP (cGAMP(3′-5′)) in Vibrio cholerae 20 . DncV has been placed in a separate protein family, the nucleotidyl transferase superfamily (NTS), on the basis of key amino acids that it shares with 2′-5′-oligo(A) synthase 1 (OAS1) and poly(A) polymerases 20 . DncV can also synthesize c-di-AMP in vitro and when overexpressed in Escherichia coli 20 . However, only the cGAMP(3′-5′) hybrid nucleotide was detected in V. cholerae extracts 20 , suggesting that the c-di-AMP activity of DncV is not physiologically relevant. Currently, the DAC domain is the only known bona fide c-di-AMPproducing cyclase domain. The finding that the different cyclic dinucleotides are produced by non-homologous enzymes might be somewhat surprising, as it would seem easier to reprogramme a DGC to synthesize c-di-AMP than to evolve a new cyclase. However, it has been noted previously that different classes of cAMP-forming cyclases do not have a common origin 21 . This highlights the fact that enzymes involved in the synthesis of the same signalling nucleotide might have evolved multiple times 21 . At the time this Review was prepared, 1,956 DAC domain-containing sequences from 1,438 organisms could be found in the Pfam database 22 (Supplementary information S1 (table) ). The majority of these proteins are found in bacterial species, but a small number are also present in archaea of the phylum Euryarchaeota 12
. In bacteria, DAC domain-containing proteins are most frequently found in members of the Gram-positive phyla Firmicutes and Actinobacteria. In addition, the DAC domain is found in Gram-negative bacteria, including members of the phyla Bacteroidetes, Cyanobacteria, Chlamydiae and Fusobacteria, and the class Deltaproteobacteria (Supplementary information S1 (table) ). Interestingly, most organisms contain only a single DAC enzyme; organisms containing two or three DAC proteins, such as some Clostridium and Bacillus spp., are an exception (Supplementary information S1 (table) ). This is in contrast to c-di-GMP production, for which most organisms encode multiple DGC enzymes. The distribution of enzymes that synthesize and degrade c-di-AMP and c-di-GMP is also different among bacteria. The c-di-GMP turnover enzymes are especially abundant among bacteria of the phylum Proteobacteria; they are found in members of the class Deltaproteobacteria, which potentially also encode a c-di-AMP synthase, but are also widespread among bacteria of the classes Alphaproteobacteria, Betaproteobacteria and Gammaproteobacteria, organisms that lack a c-di-AMP signalling system [23] [24] [25] . By contrast, c-di-GMP turnover enzymes have been reported to be absent in bacteria from the phyla Bacteroidetes and Fusobacteria and those from the order Chlamydiales 25 ,
Box 1 | Cyclic di-GMP signalling in bacteria
Cyclic di-GMP (c-di-GMP) is a well-studied bacterial second messenger that was first discovered in 1987 through work carried out in the laboratory of Moshe Benziman, when the molecule was shown to activate cellulose biosynthesis in Gluconacetobacter xylinus 81 . c-di-GMP homeostasis is controlled by the opposing actions of diguanylyl cyclases (DGCs) and phosphodiesterases (PDEs) 3, 36, 82 . Signal-dependent dimerization of GGDEF domain-containing DGCs, each bound to one molecule of GTP, results in the activation of cyclase activity and the condensation of the two GTP molecules to form c-di-GMP 36 . The dinucleotide is degraded by PDEs, which are characterized by the presence of EAL or HD-GYP domains 36 . Although most of the signals that regulate the activity of DGCs and PDEs remain to be established, several environmental cues, such as light 83 , oxygen 84 , nutrient starvation 85 , the presence of antibiotics 86 and redox state 87 , have been shown to affect the activity of these enzymes (reviewed in REFS 3, 82) . Furthermore, in some bacteria, GGDEF or EAL domain-containing proteins contain an amino-terminal receiver (REC) domain that is phosphorylated by cognate senor kinases, and in several of these bacteria, phosphotransfer systems can indirectly activate these c-di-GMP-synthesizing or c-di-GMP-degrading proteins in response to environmental changes 88, 89 . Following synthesis, c-di-GMP binds to receptor proteins and allosterically affects their activity, thus modulating specific cellular pathways. The phenotype most frequently associated with an increase in c-di-GMP levels is a switch from a motile to a biofilm-associated lifestyle 82 . Other outputs linked with alterations in cellular c-di-GMP levels include changes in virulence-related properties and regulation of the bacterial cell cycle 3, 82, 90 . A large number of receptors involved in controlling these phenotypes have now been identified, and these fall into four different classes 90 . PilZ was the first domain shown to bind c-di-GMP 81, 91 and is present in proteins that are often involved in regulating motility and the production of cellulose and alginate 81, 92 . A second class of c-di-GMP receptor is the GGDEF or EAL domain-containing proteins possessing a degenerate active site. Although these proteins are no longer capable of synthesizing or degrading c-di-GMP, they can still bind the dinucleotide and thus transduce the signal 93, 94 . A third type of c-di-GMP receptor is transcription factors such as FleQ, a master regulator of flagellar gene expression in Pseudomonas aeruginosa 39 . The final class of receptor is riboswitches, which are small mRNA segments present in the upstream UTR of some transcripts. Binding of c-di-GMP to this mRNA region regulates the transcription or translation of the downstream sequence 95 . Although much about c-di-GMP remains to be uncovered, the multiplicity of c-di-GMP DGCs and PDEs encoded in bacterial genomes, and in proteobacteria in particular, highlights the importance of this secondary messenger in enabling bacteria to switch between different lifestyles depending on specific environmental cues.
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Receptor or target protein whereas these bacteria potentially encode a c-di-AMP synthesis enzyme. However, the signalling systems are not mutually exclusive, and several bacteria appear to encode both. Among members of the phyla Firmicutes and Actinobacteria, for instance, Bacillus, Clostridium, Listeria, Mycobacterium and Streptomyces spp. seem to contain both signalling systems, whereas other species such as Staphylococcus, Streptococcus and Corynebacterium spp. no longer encode a functional c-di-GMP system (R.M.C. and A.G., unpublished observations). However, the presence of degenerate GGDEF domains in Staphylococcus and Streptococcus spp. could be a remnant of a c-di-GMP system that has now been rewired to function in c-di-AMP signalling.
Architecture of DAC domain proteins
DacA. Although the exact function of most DAC domaincontaining proteins remains unknown, an analysis of associated domains or of the operon structure in which DAC proteins are encoded can provide insights into the role of these proteins. The most abundant domain architecture for bacterial DAC proteins is one in which the DAC domain follows an N-terminal three-helix transmembrane domain (FIG. 2) . We suggest that a protein with this architecture be referred to as DacA, on the basis of the nomenclature already used in several bacterial species (FIG. 2; Supplementary information S1 (table)). It is plausible that the membrane domain of DacA acts as a sensory domain, directly sensing specific changes within the membrane or cell wall and adjusting c-di-AMP production accordingly. It has also been noted that dacA is often found in an operon with a gene encoding a protein containing one or multiple YbbR domains (PF07949) 12 (Supplementary information S1 (table) ). In a few instances, the YbbR domains are directly fused to the DAC protein, and to distinguish these proteins from DacA proteins, these 'fusion' proteins are referred to here as DacC (FIG. 2) . YbbR domains usually follow an ) physically interacts with DacA and stimulates cyclase activity 15 . The structures of two of the four YbbR domain-containing proteins from Desulfitobacterium hafniense str. Y51 have been solved by NMR and X-ray crystallography 26 . The YbbR domains assume a similar fold to the C-terminal domain of the ribosomal proteins TL5 from Thermus thermophilus and L25 from Deinococcus radiodurans 27, 28 . It has been suggested that this C-terminal domain stabilizes the interaction between the 5S rRNA, to which these ribosomal proteins bind, and the 23S rRNA via an interaction with the 23S rRNA-binding ribosomal protein L16 (REF. 26 ), highlighting the fact that a protein with a similar fold to YbbR can bind both RNA and protein. Therefore, it seems plausible that the extracellular YbbR domains of YbbR serve as sensory domains of an as-yet-unknown signal in order to regulate the activity of DacA.
The dacA operon is frequently extended to include the phosphoglucosamine mutase gene (glmM), which encodes a protein involved in one of the initial steps of peptidoglycan synthesis. In B. subtilis, this three-gene operon (comprising dacA, ybbR and glmM) is constitutively expressed from a promoter under the control of σ A , the housekeeping σ-factor 15, 16 . Along with the observed changes in cell wall structures in bacteria with altered c-di-AMP levels, which are discussed below, this suggests a link between c-di-AMP and cell wall synthesis and homeostasis.
DisA. The second most common group of DAC domaincontaining proteins are DisA proteins, in which the DAC domain is connected through a specific linker region to a DNA-binding domain (FIG. 2) . Such DisA proteins are found in some Gram-negative bacteria but are mostly present in the Gram-positive spore-forming Bacillus and Clostridium spp. and in actinobacteria (Supplementary information S1 (table)). DisA has been assigned a function as a direct sensor of DNA integrity before spore formation, and the levels of DisA increase at a high cell density and at the onset of sporulation 4, 5 . It is interesting to note that B. subtilis disA is located in a large operon together with radA, encoding a DNA repair protein, and clpC and its accessory genes mcsA and mcsB, which encode proteins involved in degrading damaged proteins, particularly during heat stress 29 . This large operon is preceded by promoters that are regulated by σ A , the housekeeping σ-factor, and σ B , the stationary phase σ-factor 30 . Expression of disA is further controlled by an internal σ M -dependent promoter that is activated by cell envelope stresses such as those elicited by antibiotics 16, 30, 31 . The observation that disA expression is controlled by multiple promoters could suggest that DisA and, hence, c-di-AMP are important to ensure that DNA integrity is maintained during multiple stresses and perhaps not only when bacteria enter sporulation. The function of the DisA homologues in actinobacteria has not yet been studied. However, as Streptomyces spp. are also spore-forming bacteria and the slow-growing Mycobacterium spp. enter a dormant state, it seems likely that, at least in these actinobacteria, DisA and c-di-AMP ensure that DNA integrity is maintained during these developmental processes.
DacB. The third most prevalent DAC domain-containing proteins are those in which a YojJ domain (PF10372) precedes the DAC domain (FIG. 2) ; these proteins are, with one exception, specific to bacteria of the order Bacillales
Box 2 | Potential cyclic di-AMP cyclases and hydrolases in archaea
On the basis of bioinformatic analysis and the occurrence of 65 diadenylyl cyclase (DAC) domain-containing proteins (see the figure, part a, and Supplementary information S1 (table)) it is likely that cyclic di-AMP (c-di-AMP) is also produced by a subset of archaea 12 .
In these organisms, the DAC domain is found primarily in cytoplasmic proteins with a stand-alone DAC domain. This architecture might suggest that these cyclases cannot directly sense environmental or cellular changes and instead need a separate sensory protein. Aside from the stand-alone DAC domain proteins, the DAC domain is, in several cases, fused to a domain annotated as a pyruvate kinase carboxy-terminal α/β C (PK_C) domain (Pfam accession PF02887). Pyruvate kinases are central metabolic enzymes involved in glycolysis. They are homotetrameric enzymes that, in bacteria and archaea, consist of three domains (A, B and C). The active site is located in the interface between domains A and B, whereas the PK_C domain can serve as the binding site for an allosteric effector 96 . It is therefore plausible that the PK_C domain in these archaeal proteins serves as a small-molecule-binding domain, which in turn regulates the cyclase activity. In other cases, the DAC domain is found in association with polycystic kidney disease I (PKD) (PF00801), tetratricopeptide repeat (TPR) or PAS domains (in one, one and two DAC proteins, respectively). These three domains have been implicated as ligand-binding or protein-protein interaction domains and therefore might serve to regulate the activity of the associated DAC domain following ligand binding. Although c-di-AMP production by archaea has yet to be confirmed experimentally, the DAC domains in these organisms have the conserved DGA amino acid signature and a conserved RH in place of the RHR motif found in active cyclases; we therefore propose that these enzymes be renamed DacV-DacZ (see the figure, part a, and Supplementary information S1 (table)).
No homologues of the c-di-AMP-degrading enzyme GGDEF domain protein containing PDE (GdpP) are present in archaea. However, proteins belonging to a different family of DHH-DHHA1 domain-containing proteins could serve this phosphodiesterase (PDE) function. Interestingly, archaeal candidates for c-di-AMP PDEs have a TrkA_N-DHH-DHHA1 domain structure (see the figure, part b). These proteins co-occur in species containing DAC domain proteins. Interestingly, the TrkA_N domain, which is also referred to as an amino-terminal regulator of conductance of potassium (RCK_N) domain, is associated with potassium or other transporters, and such transporters have been linked to the c-di-AMP signalling network in bacteria. Phosphoenolpyruvatedependent sugar phosphotransferase system EIIA A subunit of the protein EII, an enzyme responsible for the import and phosphorylation of sugars that are imported through this major carbohydrate transport system in bacteria and archaea.
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Tetratricopeptide repeat
A structural motif found in tandem arrays of 3-16 repeats. These motifs form scaffolds to promote protein-protein interactions.
(Supplementary information S1 (table) ). To provide a consistent nomenclature, proteins with this domain architecture are referred to here as DacB proteins. The structure of the Bacillus cereus DacB (Protein Data Bank accession 2fb5) revealed that the N-terminal YojJ domain forms an orthogonal bundle of long α-helices that are followed by the DAC domain, which as expected, has the same fold as the DAC domain of DisA 4 . It has been confirmed that B. subtilis DacB functions as a DAC enzyme 15, 16 . DacB does not seem to be expressed in vegetative B. subtilis cells 15 , although its expression has been shown to increase during sporulation 32 . On the basis of these transcription data, it has been suggested that dacB is under the control of σ G , the late forespore-specific σ-factor 15, 32 , and therefore that c-di-AMP produced by DacB is likely to control sporulation-specific processes.
Other DAC domain-containing proteins. DacA, DisA and DacB represent more than 98.7% of all bacterial DAC domain-containing proteins identified to date. For the remaining proteins (other than DacC proteins), the DAC domain is preceded in six cases by a phosphoenolpyruvatedependent sugar phosphotransferase system EIIA subunit (PF00359), indicating a possible link between sugar import and c-di-AMP synthesis in these organisms. In two further cases, the DAC domain is linked to differing tetratricopeptide repeat (TPR) domains (PF00515, PF13414 and PF13424) that are thought to mediate protein-protein interactions, and in one other case, it is fused to a domain of unknown function (DUF4062; PF13271). To provide a consistent nomenclature, we propose that these proteins be renamed DacD, DacE and DacF, respectively (FIG. 2; Supplementary information S1 (table)).
Degradation of c-di-AMP
Following the discovery of c-di-AMP-synthesizing proteins, the B. subtilis PDE enzyme YybT, which can hydrolyse c-di-AMP, was discovered 33 . This protein is referred to here as GGDEF domain protein containing PDE (GdpP), for consistency in nomenclature with homologues in other bacteria. gdpP is in an operon with rplI, the gene encoding ribosomal protein L9, and is also frequently located close to, if not in an operon with, the gene encoding DnaC, a protein that is important for DNA replication. Expression of the c-di-AMP-specific PDE together with a ribosomal protein and a DNA replication protein might suggest that it is important to keep c-di-AMP levels low during active growth and replication. Recently, it has been reported that gdpP expression itself is regulated in B. subtilis by an antisense transcript under the control of σ D (REF. 34 ), a transcription initiation factor that is involved in the expression of chemotaxis, motility and autolysis genes. Whether and In other phyla, it is possible that the DHH and DHHA1 domains are present in stand-alone proteins or are associated with other sensory domains, or that a different class of enzyme is responsible for c-di-AMP hydrolysis.
PAS sensory domain
A domain that is named for its conservation in the proteins Per, ARNT and Sim and their homologues. The PAS domain binds a diverse range of smallmolecule ligands (for example, haem and FAD) and is often involved in redox and light responses.
DHH domain
A domain that is found in a family of phosphatases and is characterized by the presence of a conserved DHH amino acid motif.
Surface plasmon resonance
A way of measuring the interaction of macromolecules at a surface through changes in the refractive index. Valence electrons of molecules at a metal-liquid interface oscillate in response to incident light. When one ligand is immobilized on a metal surface (for example, using a hexahistidine tag) and a second ligand is passed across the surface, the association and dissociation of the two ligands result in a change of refractive index, which can be measured.
Major facilitator family transporter
A family of transporters that are responsible for transporting small solutes across the membrane in response to chemiosmotic ion gradients.
how this antisense regulation translates into changes in cellular c-di-AMP levels awaits further investigation. GdpP contains two transmembrane helices, a degenerate PAS sensory domain (PF00989), a highly divergent GGDEF domain, a DHH domain (PF01368) and a DHH-associated DHHA1 domain (PF02272) (FIG. 2) . The PDE activity is contained within the C-terminal DHH-DHHA1 region, which efficiently degrades c-di-AMP to pApA (FIG. 1) with a Michaelis constant (K m ) of 1.3 ± 0.3 μM 33 . GdpP requires manganese for activity, and mutations of predicted and conserved metal-binding residues abrogate the PDE activity of B. subtilis and S. aureus GdpP enzymes 10, 33 . Using an in vitro assay, it has been shown that haem binding to the PAS domain suppresses the PDE activity of GdpP, whereas nitric oxide coordination by haem stimulates the PDE activity 35 . This suggests that GdpP is a haem and/or nitric oxide sensor and coordinates the degradation of c-di-AMP accordingly. GdpP also contains a highly modified GGDEF domain. GGDEF domains are typically associated with proteins involved in the synthesis of c-di-GMP, in which two GGDEF domains, each bound to one molecule of GTP, produce c-di-GMP 36 . However, in some instances, when a GGDEF and a PDE domain are present within a single protein, such as in the c-di-GMP-degrading enzyme PdeA from Caulobacter crescentus, GTP binding does not result in the synthesis of c-di-GMP, but instead regulates the activity of the PDE domain 37 . The GGDEF motif in GdpP is highly modified and produces neither c-di-GMP nor c-di-AMP 33 . Instead, this domain binds ATP and slowly hydrolyses it to ADP 33 , but the physio logical relevance of this enzymatic activity remains to be determined. Binding of a non-hydrolysable ATP analogue does not affect the PDE activity of B. subtilis GdpP 33 , but mutations of several conserved amino acids within the GGDEF domain in S. aureus GdpP significantly reduce c-di-AMP hydrolysis 10 , suggesting a regulatory function for this domain. It is also interesting to note that the stringent response signalling molecule (p)ppGpp is a strong competitive inhibitor of GdpP activity in vitro 33 . This not only links the networks of two different signalling nucleotides, but also suggests that under stringent response stress conditions, cellular c-di-AMP levels increase through a decrease in PDE activity.
GdpP-type proteins containing PAS, GGDEF and DHH-DHHA1 domains together are found only in members of the phyla Firmicutes and Tenericutes (Supplementary information S1 (table)), so as-yetunidentified proteins with different domain architectures (potentially a DHH-DHHA1 domain in a stand-alone protein or associated with a different sensory domain) must be responsible for c-di-AMP degradation in other bacteria (FIG. 2) . Potential c-di-AMP-hydrolysing enzymes of archaea are discussed in BOX 2.
c-di-AMP: an essential second messenger Bacterial production of c-di-AMP was first discovered in 2010, when the intracellular pathogen L. monocytogenes was found to secrete the molecule into the cytosol of host cells 6 . As much as 18 nM of c-di-AMP was detected in the supernatant of wild-type L. monocytogenes cultures, and this increased to 53 nM when multidrug efflux pumps were overexpressed 6 . Subsequently, intracellular c-di-AMP concentrations of 1.7 μM and 2.1 μM have been measured in cytoplasmic extracts of B. subtilis and S. aureus cells, respectively, and the concentrations have been shown to increase to fourfold and 15-fold above wild-type levels in the respective gdpP mutant strains 8, 10 . These nucleotide concentrations are in a similar range to those reported for c-di-GMP 38, 39 . c-di-AMP was also found to be produced by Streptococcus pyogenes, and attempts to delete dacA in this species and also in L. monocytogenes proved unsuccessful, hinting that the cyclase, and hence c-di-AMP, is essential in these bacteria 6, 7, 40 . These results are also in line with genome-wide screens for essential genes in Mycoplasma pulmonis, Mycoplasma genitalium, Streptococcus pneumoniae and S. aureus [41] [42] [43] [44] , all of which reported an inability to disrupt dacA. Furthermore, a B. subtilis mutant with deletions in all three cyclase genes (disA, dacA and dacB) could not be obtained, but ectopic expression of any of the three cyclases was enough to fully rescue the triple mutant, suggesting that all three proteins are active cyclases when expressed 15, 16 . As c-di-AMP is produced by many important human pathogens, these observations highlight the need to identify the cellular pathways that are regulated by c-di-AMP, with a view to possibly exploiting these pathways to develop new therapeutic interventions.
c-di-AMP receptors
Signalling nucleotides function by binding to specific receptor proteins to allosterically alter receptor activity and thus regulate particular cellular pathways. Several receptors for c-di-AMP have recently been identified (FIG. 3) .
The TetR family transcription factor DarR. The first c-di-AMP receptor reported in the literature was the M. smegmatis protein Ms5346, a tetracycline resistance (TetR) family regulator that was renamed c-di-AMP receptor regulator (DarR). DarR was identified by screening a library of ~500 predicted M. smegmatis transcription factors for their ability to bind radiolabelled c-di-AMP 13 . Using surface plasmon resonance, a specific interaction with a dissociation constant (K d ) of 2.5 μM was revealed between purified DarR and c-di-AMP. DarR has a two-domain architecture with an N-terminal TetR-like helix-turn-helix domain (PF00440), which is a typical DNA-binding domain, and a C-terminal QacRlike (PF08360) domain 13 (FIG. 3a) . Proteins containing QacR-like domains are not universally present in organisms that are likely to produce c-di-AMP; however, this domain is present in QacR (a protein found in some S. aureus strains), fatty acid metabolism regulator (FadR) from B. subtilis and the transcriptional regulator AcrR from Pelotomaculum thermopropionicum 13 . In M. smegmatis, DarR binds to and represses transcription from its own promoter, as well as the promoter of the divergently transcribed operon, which encodes a medium-chain fatty acyl-CoA ligase and a major facilitator family transporter. In addition, DarR represses transcription of a gene encoding cold shock protein A (CspA) (FIG. 4) . Deletion Nature Reviews | Microbiology of darR in M. smegmatis leads to an increase in cell size, whereas overexpression is toxic to the bacterium and causes a marked decrease in fatty acid synthesis 13 . The DNA-binding ability of DarR is enhanced in vitro following interaction with c-di-AMP 13 , suggesting that changes in cellular c-di-AMP levels affect fatty acid synthesis in M. smegmatis. However, additional experimental evidence is needed to unambiguously show that c-di-AMP affects membrane lipid homeostasis in M. smegmatis or other bacteria (FIG. 4) .
The RCK_C domain proteins KtrA and CpaA. Using affinity pull down assays, the S. aureus protein KtrA, a cytoplasmic gating component of Ktr-type potassium transport systems, was identified as a second c-di-AMP receptor 14 . Purified KtrA binds c-di-AMP with a higher affinity than DarR and has a K d of below 100 nM 14 . Together with a KtrB-type membrane component, KtrA forms a potassium transporter that is widely distributed among bacteria 45, 46 (FIG. 3) . KtrA is a member of the regulator of conductance of potassium family (RCK family; also known as the KTN family) and is composed of an N-terminal RCK_N domain (PF02254) and a C-terminal RCK_C domain (PF02080) (FIG. 3b) . The RCK_N domain has been shown to bind nucleotides, including ATP, ADP, NAD + and NADH, but c-di-AMP binds specifically to the RCK_C domain 14 (FIG. 3b) . It is thought that nucleotide binding to KtrA leads to either a conformational change or a change in the oligomerization state that is transduced to the membrane transporter component, KtrB (FIG. 4) , leading to channel opening or closing. S. aureus KtrA is essential for bacterial growth in low-potassium conditions 14 . Furthermore, gdpP-mutant bacteria, which have high levels of c-di-AMP, are sensitive to salt stress and, similarly to a ktrA-mutant strain, require high levels of potassium for growth under osmotic stress conditions 14, 47 . However, additional experiments are needed to unambiguously determine how binding of the second messenger c-di-AMP to KtrA affects the activity of the potassium transporter. It has previously been demonstrated that other nucleotides such as cAMP and cGMP are involved in the gating of potassium channels 48 . The discovery of the RCK_C domain as a c-di-AMP receptor led to the subsequent identification of S. aureus cation proton antiporter A (CpaA; encoded by the locus SAV1010) as a third c-di-AMP-binding protein 14 (FIGS 3c,4). Although the RCK_C domains of KtrA and CpaA have low identity, structural homology models indicate that they are likely to assume similar folds. As CpaA is also a predicted ion transporter, it is likely to be involved in the uptake of potassium or sodium in exchange for an intracellular proton 14 . The RCK_C domain is associated with potassium transporters or channels and other transporters. This domain is more widely distributed than the DAC domain, being found in bacteria and archaea, and also in a small subset of eukaryotic green algae in which the DAC domain is absent. However, organisms that have a DAC domaincontaining protein usually contain one or more proteins with an RCK_C domain, indicating that c-di-AMP regulates potassium and perhaps other transport processes in a variety of organisms.
The histidine kinase KdpD. Following on from this, a further c-di-AMP target protein was identified in S. aureus using a whole-genome screening approach 14 . This protein, KdpD, also has a potential role in potassium homeo stasis 
Bacillus subtilis
and, in addition, has been implicated as a regulator of virulence and intracellular survival in a number of bacterial pathogens 49 . KdpD is a histidine kinase that, together with its cognate response regulator, KdpE, controls the expression of a second type of potassium uptake system in many bacteria (FIGS 3d,4) . In contrast to the Ktr system, the Kdp system is an ATP-dependent potassium uptake system and in E. coli consists of four membrane components, KdpFABC. The two-component system KdpDE is required for the expression of KdpFABC at low potassium concentrations, when the other potassium uptake systems are no longer sufficient for adequate ion uptake 45 . KdpD is a predicted membrane protein with N-terminal and C-terminal cytoplasmic regions that contain multiple domains (FIG. 3d) . The protein contains neither an RCK_C nor a QacR-like domain, and the protein region that interacts with c-di-AMP still needs to be determined. The role of the Kdp system in potassium uptake . In the case of CpaA, c-di-AMP binding is thought to directly affect ion transport. KtrA interacts with the effector protein KtrB, a membrane component responsible for the uptake of potassium. It is thought that nucleotide binding to KtrA leads to either a conformational change or a change in the oligomerization state that is transduced to the membrane transporter component, KtrB, resulting in a change in potassium uptake activity 14 . KdpD phosphorylates the response regulator KdpE, which might also have a downstream effect on potassium uptake. The function of PstA is unknown 14 . On the basis of in vitro activity data, it is thought that the c-di-AMP-specific enzyme GGDEF domain protein containing PDE (GdpP) senses intracellular haem through an interaction with the PAS domain (green), resulting in decreased phosphodiesterase (PDE) activity of GdpP, whereas nitric oxide (NO) binding to haem results in an increase in PDE activity and, potentially, a decrease in the cellular c-di-AMP concentration 37 . B. subtilis has two additional c-di-AMP cyclases, DNA integrity scanning protein (DisA) and DacB. The sensory function of DisA is the best characterized. This protein binds to DNA via the helix-hairpin-helix (HhH) domain, and on detection of branched DNA, c-di-AMP synthesis stops, so cellular c-di-AMP levels drop 4, 5 . DacB has an associated YojJ domain (orange) that might be involved in sensing as-yet-unknown intracellular signals, and on the basis of expression data, it has been suggested that DacB is active during sporulation 32 . In Mycobacterium smegmatis, c-di-AMP is synthesized by a DisA protein and has been demonstrated to bind to the transcriptional repressor c-di-AMP receptor regulator (DarR) and increase the association of DarR with the promoter regions of three genes: the cold shock protein A gene (cspA), a medium-chain fatty acyl-CoA ligase gene and a major facilitator family transporter gene 13 . In all cases, it is assumed that at high c-di-AMP levels, the nucleotide will bind to these or other unknown receptors and, in doing so, will allosterically modify receptor function. In this way, changes in c-di-AMP levels affect ion transport, cell wall homeostasis and the sensing of DNA integrity and, through DacB, perhaps function in the sporulation processes in B. subtilis, as well as in membrane homeostasis in M. smegmatis.
Lipoteichoic acid
A cell wall polymer that, in many cases, consists of a polyglycerol phosphate chain which is inserted into the bacterial membrane through a glycolipid anchor.
Type I interferon response
An immune response that is traditionally associated with viral infection, but is now known to also be important in the response to bacteria. It involves the secretion of cytokines, including interferon-α (IFNα) and IFNβ, by many mammalian cells.
in S. aureus has not been fully elucidated, and additional work is needed to understand the function of this two-component system and its interplay with cellular c-di-AMP levels.
Potassium transport is of fundamental importance in all living cells. In bacteria, potassium has essential roles in adapting to changes in osmolarity, controlling the activity of intracellular enzymes, regulating internal pH and maintaining an appropriate membrane potential 45 .
The link between c-di-AMP signalling and ion homeostasis may therefore explain, in part, why this nucleotide is important for bacterial survival.
The PII-like signal transduction protein PstA. The final c-di-AMP receptor identified to date is a PII-like signal transduction protein that has been named PstA (encodded by the locus SACOL0525) 14 . This S. aureus protein was again discovered using a whole-genome screen 14 . PstA is a predicted cytoplasmic protein containing a DUF970 domain of unknown function (PF06153) (FIG. 3e) . Structurally, this domain resembles a ferredoxin-like αβ sandwich, which is also found in the cation tolerance protein CutA1 (REF. 50 ) and the ATP phosphoribosyltransferase HisG, the first enzyme of the histidine synthesis pathway 51 . However, the best characterized proteins with this structural domain are PII nitrogen regulatory proteins belonging to the GlnB superfamily. These are key signal transduction proteins that respond to the nitrogen and carbon status of cells by sensing glutamine and 2-ketoglutarate levels 52 . Although any link is as yet unconfirmed, it will be interesting to discover whether PstA plays a part in nitrogen regulation in S. aureus and how this role is affected by c-di-AMP levels.
Other cellular processes influenced by c-di-AMP Cell wall homeostasis. In several recent studies, alterations in cellular c-di-AMP levels have been connected to changes in the bacterial cell wall. For instance, S. aureus mutants lacking the essential cell wall polymer lipoteichoic acid (LTA) regain the ability to grow almost normally on inactivation of GdpP; this inactivation leads to a 15-fold increase in intracellular c-di-AMP levels 10 . Furthermore, an S. aureus strain in which gdpP is mutated has increased amounts of crosslinked peptido glycan, which is hypothesized to help bacteria compensate for the lack of LTA. Microscopic analysis of wild-type and gdpP-mutant strains revealed a 13-22% reduction in the cell size of S. aureus with increased c-di-AMP levels 10 . S. aureus, B. subtilis and L. mono cytogenes strains carrying a mutated gdpP display increased resistance to β-lactam antibiotics, further indicating that changes in the cell wall occur in strains with high c-di-AMP levels 10, [16] [17] [18] [19] 40 . Conversely, on overexpression of GdpP, which decreases c-di-AMP levels, B. subti lis and L. monocytogenes become highly sensitive to cell wall-targeting antibiotics 16, 40 . Finally, Lactococcus lactis, L. monocytogenes and B. subtilis gdpP-mutant strains are more resistant to acid 33, 40, 53 and heat stress 47 . Together, these data suggest that c-di-AMP is involved in controlling S. aureus cell wall synthesis and cell size and in helping this bacterium to cope with membrane and cell wall damage, acid exposure and heat stress (FIG. 4) . The molecular mechanisms responsible for these processes are not yet understood. We speculate that several of these phenotypes are linked to an altered ability to take up potassium under varying c-di-AMP concentrations. Potassium is important for the maintenance of an adequate membrane potential, which is known to contribute to antibiotic resistance 54, 55 . This metal also plays a crucial part in osmoregulation, a function for which an intact cell wall is also crucial 45 . Last, potassium uptake is required for pH homeostasis, another phenotype that has been linked to differences in c-di-AMP levels 33 .
Sensing of DNA damage. DisA is an octameric protein that binds DNA at a single focus via the C-terminal HhH domain and scans the chromosome while synthesizing c-di-AMP 4, 5 (FIG. 4) . The movement of the DisA focus is dependent on the ability of this protein to synthesize c-di-AMP 5, 8 . On the detection of branched DNA, such as a Holliday junction or a stalled replication fork, DisA movement and c-di-AMP synthesis cease 4, 8 (FIG. 4) . This decrease in c-di-AMP levels is believed to act as a signal to stop replication until the DNA can be repaired, potentially through the action of RadA. It has been reported that DisA expression increases during late exponential phase and during sporulation 5 . This results in a threefold increase in c-di-AMP levels in cells that are undergoing sporulation compared with vegetative cells 8 . When DNA damage is sensed by DisA before the onset of sporulation, the levels of c-di-AMP drop, resulting in a delay in the onset of sporulation, and this delay can be reversed by the exogenous addition of c-di-AMP 8 . Furthermore, GdpP expression increases in B. subti lis cells that have been exposed to a DNA-damaging agent, and again, this results in a decline in c-di-AMP levels and a decreased sporulation rate 8 . In this way, c-di-AMP levels act as an indicator of DNA integrity and help to ensure that only undamaged DNA is packed into spores in B. subtilis.
Induction of eukaryotic host cell responses. In addition to its functions in bacterial physiology, c-di-AMP is sensed by eukaryotic host cells and has recently been shown to elicit a type I interferon response (type I IFN response). This response is a well-characterized innate immune response leading to the activation of defence mechanisms against viral infection. However, more recently, it has been recognized that both extracellular and intracellular bacterial pathogens can also induce a type I IFN response, and the activator molecules and signalling pathways responsible are beginning to be identified (FIG. 5) .
L. monocytogenes is an intracellular pathogen that, after entering a eukaryotic host cell, escapes from the vacuolar compartment and then resides and propagates in the cytosol. There, c-di-AMP is secreted by the bacterium through the multidrug efflux pumps MdrM and MdrT, the expression of which is controlled by the regulators multiple antibiotic resistance R (MarR) and TetR [56] [57] [58] . Like its counterpart c-di-GMP, c-di-AMP then Nature Reviews | Microbiology induces a type I IFN response, leading to the production of IFNβ 6, 58 (FIG. 5) . This response is dependent on the host cell helicase DDX41 (REF. 59 ), as well as the transmembrane receptor STING 60, 61 . Both human and mouse cell lines depleted for DDX41 or STING, as well as STINGknockout mice and mice harbouring a loss-of-function mutation in Sting, no longer elicit a type I IFN response during infection with L. monocytogenes 59, 60, 62 . An interaction between STING and c-di-GMP has been reported in several studies 61, [63] [64] [65] [66] . This, together with the STINGc-di-GMP co-crystal structure [63] [64] [65] [66] [67] , identified this protein as a receptor for c-di-GMP. The interaction between c-di-GMP and STING can be inhibited in a dosedependent manner by c-di-AMP, suggesting that STING is also a receptor for c-di-AMP 61 . However, very recently, a direct interaction between c-di-GMP and DDX41 -more specifically, the DEAD box domain of DDX41 -was reported, and c-di-AMP was also demonstrated to bind to this helicase 59 . Given that DDX41 has a higher affinity than STING for c-di-GMP, it has been suggested that DDX41 is the actual sensor, not only for cytosolic B-DNA but also for cyclic dinucleotides, and that cyclic dinucleotide-bound DDX41 then forms a complex with STING, which is proposed to act as a co-receptor 59 . However, it should be noted that, as yet, no binding affinities between c-di-AMP and either DDX41 or STING have been determined, and further work is needed to fully ascertain whether c-di-AMP is a biologically relevant ligand for either of these eukaryotic proteins.
When STING is activated, it interacts with and activates the kinase TBK1 (REF. 68 ). This in turn leads to phosphorylation of the transcription factor IFNregulatory factor 3 (IRF3), which then translocates into the nucleus and activates the type I IFN response and production of IFNβ (FIG. 5) . Whether this is advantageous to L. monocytogenes or the host, or is just a by-product of the bacterium regulating intracellular c-di-AMP levels by transporting it out of the cell, remains to be determined. Regardless of whether this response is beneficial or detrimental to the bacterium, multidrug resistance transporters are conserved among bacteria, and other species (such as S. aureus) can also enter the host cell cytosol. It therefore seems possible that c-di-AMP is secreted by several bacterial pathogens, potentially leading to immune recognition and/or modulation. However, the matter is even more complex, as it was recently shown that following the detection of foreign DNA in the cytosol, eukaryotic cells themselves can synthesize a cGAMP species 69, 70 . This eukaryotic dinucleotide, which contains a 2′-5′ linkage and hence is referred to here as cGAMP(2′-5′), is distinct from the bacterial dinucleotide cGAMP(3′-5′) [71] [72] [73] [74] . cGAMP(2′-5′) can also bind the receptor protein STING to activate a type I IFN response [69] [70] [71] [72] [73] [74] (FIG. 5) . These studies have also shown that the cytosolic DNA binds directly to the eukary otic cGAMP synthase (cGAS) and stimulates enzyme activity, leading to the production of cGAMP(2′-5′) 67, 72, 73 . The recognition of cyclic dinucleotides as immunomodulatory and immunostimulatory molecules prompted further research into their potential use as vaccine adjuvants. There are now several promising reports describing a beneficial effect for c-di-GMP and c-di-AMP as adjuvants for both mucosal and systemic vaccinations, highlighting another potential use for these molecules [75] [76] [77] [78] . 97 . This recognition leads to activation of the kinases TBK1 and inducible IκB kinase (iIKK) through the myeloid differentiation primary response protein 88 (MYD88) or TIR domain-containing adapter inducing IFNβ (TRIF) pathway 98 . Activated TBK1 in turn phosphorylates IFN-regulatory factor 3 (IRF3), resulting in IFN3 translocation across the nuclear membrane and induction of a type I interferon (IFN) response 68 . By contrast, the intracellular bacterial pathogen Listeria monocytogenes enters eukaryotic host cells and is initially contained within a vacuolar compartment, where it avoids detection by the host. However, L. monocytogenes can escape from the vacuole and enter the cytosol, where some of the dinucleotide cyclic di-AMP (c-di-AMP) pool is secreted 6 .There is some evidence that c-di-AMP binds to the eukaryotic helicase DDX41, which in turn interacts with and activates the co-receptor STING 59 . Alternatively, it has been suggested that c-di-AMP interacts directly with the cytosolic portion of STING [60] [61] [62] [63] [64] [65] [66] . Activated STING can then interact with and activate the kinase TBK1 (REF. 68 ), again leading to phosphorylation and translocation of IRF3, activation of the type I IFN response and the production of IFNβ. STING is also the receptor for cyclic di-GMP and can additionally be activated by double-stranded DNA and the eukaryotic 2′-5′-linked cyclic GMP-AMP (cGAMP(2′-5′)) 65, [68] [69] [70] [71] [72] [73] [74] 99 . This eukaryotic cyclic dinucleotide is synthesized by the cytoplasmic enzyme cGAMP synthase (cGAS) in response to the sensing of DNA in the cell.
Unresolved questions
Since the discovery of c-di-AMP in a structural study in 2008, its production by several bacteria has now been confirmed experimentally. Given the many phenotypes associated with altered c-di-AMP levels, there is no longer any doubt that this molecule has an important role as a second messenger, and some of the target proteins and cellular pathways that are controlled by this dinucleotide have now been identified (FIG. 4) . Despite these advances, there are many outstanding questions. First, in the majority of microorganisms, c-di-AMP production is inferred from the occurrence of DAC domaincontaining proteins and remains to be confirmed. Likewise, the corresponding c-di-AMP-degrading enzymes need to be confirmed in bacteria outside the phylum Firmicutes and in archaea. Currently, only one signal, DNA damage, has been directly linked to changes in c-di-AMP levels 4, 5, 8 . However, it is expected that other signals will affect c-di-AMP synthesis, especially in those organism lacking DisA homologues (FIG. 4) . But the focus of most current research is on identifying other c-di-AMP receptor and effector proteins.
As most organisms contain only a single DAC enzyme, the c-di-AMP network seems to be much simpler than the c-di-GMP signalling network, for which organisms often contain more than twenty proteins with cyclase and hydrolase domains. Therefore, one might expect to find fewer receptor proteins and induction signals for c-di-AMP than for c-di-GMP; however, given the observed phenotypes associated with changes in c-di-AMP levels, it seems likely that in addition to the targets described here, other proteins can bind c-di-AMP. This would be similar to the 'simpler' cAMP and (p)ppGpp signalling systems, which function through several different effector proteins and have a broad physiological impact, despite the limited number of turnover enzymes 1, 2 . Recently, we have seen the development of novel tools such as chemically modified nucleotide analogues that can be used in combination with sensitive mass spectrometry methods for the capturing and identification of receptor proteins, as well as a new, simple and fast binding assay suitable for highthroughput screening assays 79, 80 . These tools will make the rapid discovery of additional c-di-AMP receptors possible and guarantee an exciting future for this field.
